Evidence map›Paper›PMID 36748295›Full record

ArticleJournal of the peripheral nervous system : JPNS2023

Validation of the parent-proxy pediatric Charcot-Marie-Tooth disease quality of life outcome measure.

Tong Tong Wu, Richard S Finkel, Carly E Siskind, Shawna M E Feely, Joshua Burns, Mary M Reilly, Francesco Muntoni, Timothy Estilow, Michael E Shy, Sindhu Ramchandren and 1 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Journal of the peripheral nervous system : JPNS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Charcot-Marie-Tooth disease and related neuropathies.Nature reviews. Disease primers · 2026
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 3 countries.

Tong Tong WuDepartment of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA.
Richard S FinkelCenter for Experimental Neurotherapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Carly E SiskindDepartment of Neurology, Stanford University, Stanford, California, USA.
Shawna M E FeelyDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Joshua BurnsFaculty of Medicine and Health; Pediatric Gait Analysis Service of New South Wales. Sydney Children's Hospitals Network, University of Sydney School of Health Sciences, Sydney, New South Wales, Australia.
Mary M ReillyCentre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Francesco MuntoniCentre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Timothy EstilowDepartment of Pediatrics, Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Michael E ShyDepartment of Neurology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.ORCID 0000-0001-8460-6971
Sindhu RamchandrenDepartment of Neurology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-5201-9200
Childhood CMT Study Group of the Inherited Neuropathy Consortium
University of Iowa Hospitals and Clinics · USChildren's Hospital of Philadelphia · USGreat Ormond Street Hospital · GBJohnson & Johnson (United States) · USNational Hospital for Neurology and Neurosurgery · GBStanford University · USSt. Jude Children's Research Hospital · USThe University of Sydney · AUUniversity of Rochester · US

Funding

trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI SHY, MICHAEL E. · 2009 to 2023
$19.6M
Validation of a Disease-Specific Instrument for Pediatric Inherited NeuropathyK23NS072279 · NINDS · WAYNE STATE UNIVERSITY · PI RAMCHANDREN, SINDHU · 2011 to 2014
$692k
NINDS NIH HHS K23 NS072279NINDS NIH HHS U54 NS065712
6 · The paper itself

Abstract

Charcot-Marie-Tooth disease (CMT) reduces health-related quality of life (QOL) in children. We have previously developed and validated the English and Italian versions of the pediatric CMT-specific QOL outcome measure (pCMT-QOL) for children aged 8 to 18. There is currently no parent-proxy CMT QOL outcome measure for use in clinical trials, which could provide complementary information in these children and adolescents. This study describes the validation studies conducted to develop the parent-proxy version of the pCMT-QOL outcome measure for children aged 8 to 18 years old. Development and validation of the parent-proxy version of the pCMT-QOL outcome measure for children aged 8 to 18 years old was iterative, involving identifying relevant domains, item pool generation, prospective pilot testing and clinical assessments, structured focus-group interviews, and psychometric testing, conducted on parents of children with CMT seen at participating sites from the USA, United Kingdom, and Australia. We utilized previously described methods to develop a working parent-proxy version of the pCMT-QOL measure. From 2010 to 2016, the parent-proxy pCMT-QOL working version was administered to 358 parents of children with CMT aged 8 to 18, seen at the participating study sites of the Inherited Neuropathies Consortium. The resulting data underwent rigorous psychometric analysis, including factor analysis, test-retest reliability, internal consistency, convergent validity, IRT analysis, and longitudinal analysis, to develop the final parent-proxy version of the pCMT-QOL outcome measure for children aged 8 to 18 years old. The parent-proxy version of the pCMT-QOL outcome measure is a reliable, valid, and sensitive proxy measure of health-related QOL for children aged 8 to 18 with CMT.

Indexed as

Charcot-Marie-Tooth DiseaseQuality of LifeAdolescentChildHumansParentsProspective StudiesPsychometricsReproducibility of ResultsSurveys and QuestionnairesCharcot-Marie-tooth disease (CMT)clinical trial endpointoutcome measure validationpediatricquality of life (QOL)

Identifiers

PMID36748295
PMCPMC10521146
OpenAlexW4319333416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.